133 related articles for article (PubMed ID: 7853858)
1. Treatment strategies for the cognitive deficits of Alzheimer's disease.
Meador KJ
J S C Med Assoc; 1994 Nov; 90(11):543-7. PubMed ID: 7853858
[No Abstract] [Full Text] [Related]
2. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
Strnad J; Bahro M
Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
[No Abstract] [Full Text] [Related]
3. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
Senin U; Cherubini A; Palumbo B; Mecocci P
Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
[No Abstract] [Full Text] [Related]
5. Galantamine for Alzheimer's disease and mild cognitive impairment.
Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
[No Abstract] [Full Text] [Related]
6. Tacrine approved for cognitive deficits in Alzheimer's disease.
Nurse Pract; 1994 Jan; 19(1):6-8. PubMed ID: 8139805
[No Abstract] [Full Text] [Related]
7. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
9. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2014; 41(4):961-1019. PubMed ID: 24898652
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
[No Abstract] [Full Text] [Related]
11. [Alzheimer drugs for mild cognitive impairment].
Fellgiebel A
Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
[TBL] [Abstract][Full Text] [Related]
12. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
Relkin NR
Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
[TBL] [Abstract][Full Text] [Related]
13. [Current and future medical treatment of Alzheimer's disease].
Lemper JC
Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
15. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
Geldenhuys WJ; Van der Schyf CJ
Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055
[TBL] [Abstract][Full Text] [Related]
16. New approaches in the treatment of Alzheimer's disease.
Mintzer JE; Bachman D
J S C Med Assoc; 1994 Nov; 90(11):553-9. PubMed ID: 7853859
[No Abstract] [Full Text] [Related]
17. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: clinical features and pharmacologic management.
Franks AS; Rawls WN
Am J Manag Care; 1998 Apr; 4(4):595-604; quiz 606-7. PubMed ID: 10179918
[No Abstract] [Full Text] [Related]
19. [Treatment for non-cognitive symptoms in Alzheimer's disease].
Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J
Rev Neurol; 1999 Nov 1-15; 29(9):819-24. PubMed ID: 10696656
[TBL] [Abstract][Full Text] [Related]
20. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
Hake AM
Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
